S100A11 Overexpression Promotes Fatty Liver Diseases via Increased Autophagy?
- PMID: 33290740
- PMCID: PMC7900834
- DOI: 10.1016/j.jcmgh.2020.11.013
S100A11 Overexpression Promotes Fatty Liver Diseases via Increased Autophagy?
Comment on
-
S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis.Cell Mol Gastroenterol Hepatol. 2021;11(3):697-724. doi: 10.1016/j.jcmgh.2020.10.006. Epub 2020 Oct 17. Cell Mol Gastroenterol Hepatol. 2021. PMID: 33075563 Free PMC article.
References
-
- Diehl A.M., Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med. 2017;377:2063–2072. - PubMed
-
- Chao X., Wang S., Zhao K., Li Y., Williams J.A., Li T., Chavan H., Krishnamurthy P., He X.C., Ballabio L.L.A., Ni H.M., Ding W.X. Impaired TFEB-Mediated Lysosome Biogenesis and Autophagy Promote Chronic Ethanol-Induced Liver Injury and Steatosis in Mice. Gastroenterology. 2018;155:865–879. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous